RecruitingPhase 1NCT06224660

Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Studying Dilated cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sardocor Corp.
Intervention
SRD-001(genetic)
Enrollment
12 enrolled
Eligibility
18 years · MALE
Timeline
20242030

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06224660 on ClinicalTrials.gov

Other trials for Dilated cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Dilated cardiomyopathy

← Back to all trials